Trial
NCT03325465
Neoadjuvant Pembrolizumab + Epacadostat Prior to Curative Surgical Care for Squamous Cell Carcinoma of the Head and Neck
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
University of Chicago
Collaborators
—
Condition
Squamous Cell Carcinoma of the Head and Neck
Intervention
Pembrolizumab
Why stopped
Site decided not to move forward with trial. Study never opened to enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-04-22